Literature DB >> 8845610

Effects of calcium in continuous cardioplegia on myocardial protection.

N Takemoto1, H Kuroda, Y Nakamura, T Ichiba, N Matsuda, Y Ashida, T Hamasaki, Y Hara, S Ishiguro, T Mori.   

Abstract

The effects of calcium (Ca) on a hyperkalemic cardioplegic solution for continuous cardioplegia were examined in an isolated perfused working rat heart model. The coronary arteries were perfused with a modified Krebs-Henseleit bicarbonate buffer (K-H) solution, containing various concentrations of Ca (0.1, 0.6, 1.2, and 2.5 mmol/l) and a high concentration of potassium (20 mmol/l), for 180 min, after which cardiac arrest was induced at 37 degrees C for 180 min. Cardiac function and creatine kinase (CK) were measured. In the control group, K-H solution was infused in place of the cardioplegic solution, and cardiac arrest was not induced. No significant differences were observed between the groups infused with the K-H solution containing Ca concentrations of 0.6, 1.2, and 2.5 mmol/l in the percent recovery of aortic flow (82.1 +/- 2.9%, 80.6 +/- 2.0%, and 71.5 +/- 3.7% (mean +/- SEM) respectively) or in the recovery of other indices of cardiac function, or in CK leakage. There were also no significant differences in the recovery of cardiac function and CK leakage between these groups and the control group. In the Ca 0.1 mmol/l group, however, the characteristic Ca paradox was observed. These findings suggest that if the Ca concentration in a cardioplegic solution is higher than 0.6 mmol/l during continuous cardioplegia, excellent cardioprotective effects will be achieved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845610     DOI: 10.1007/bf00311503

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation.

Authors:  G A Geffin; T R Love; W G Hendren; D F Torchiana; J S Titus; B E Redonnett; D D O'Keefe; W M Daggett
Journal:  J Thorac Cardiovasc Surg       Date:  1989-08       Impact factor: 5.209

2.  The myocardial cell surface, its histochemistry, and the effect of sialic acid and calcium removal on its stucture and cellular ionic exchange.

Authors:  J S Frank; G A Langer; L M Nudd; K Seraydarian
Journal:  Circ Res       Date:  1977-11       Impact factor: 17.367

3.  Comparative myocardial protection with calcium-free versus calcium-containing potassium cardioplegic solutions.

Authors:  P G Magee; T J Gardner; J T Flaherty; B H Bulkley; R A Goldman; V L Gott
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

4.  Effect of pressure development on oxygen consumption by isolated rat heart.

Authors:  J R Neely; H Liebermeister; E J Battersby; H E Morgan
Journal:  Am J Physiol       Date:  1967-04

5.  Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.

Authors:  K Kinoshita; M Oe; K Tokunaga
Journal:  J Thorac Cardiovasc Surg       Date:  1991-04       Impact factor: 5.209

6.  The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrest.

Authors:  R M Engelman; J Auvil; M J O'Donoghue; S Levitsky
Journal:  J Thorac Cardiovasc Surg       Date:  1978-04       Impact factor: 5.209

7.  Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates.

Authors:  D J Hearse; D A Stewart; M V Braimbridge
Journal:  J Thorac Cardiovasc Surg       Date:  1978-07       Impact factor: 5.209

8.  Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection.

Authors:  T A Salerno; J P Houck; C A Barrozo; A Panos; G T Christakis; J G Abel; S V Lichtenstein
Journal:  Ann Thorac Surg       Date:  1991-02       Impact factor: 4.330

9.  Warm heart surgery.

Authors:  S V Lichtenstein; K A Ashe; H el Dalati; R J Cusimano; A Panos; A S Slutsky
Journal:  J Thorac Cardiovasc Surg       Date:  1991-02       Impact factor: 5.209

10.  Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.

Authors:  L A Robinson; D L Harwood
Journal:  J Thorac Cardiovasc Surg       Date:  1991-02       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.